160 related articles for article (PubMed ID: 11685107)
1. Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
Seehofer D; Rayes N; Naumann U; Neuhaus R; Müller AR; Tullius SG; Berg T; Steinmüller T; Bechstein WO; Neuhaus P
Transplantation; 2001 Oct; 72(8):1381-5. PubMed ID: 11685107
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
[TBL] [Abstract][Full Text] [Related]
3. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
[TBL] [Abstract][Full Text] [Related]
4. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
[TBL] [Abstract][Full Text] [Related]
5. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z
Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436
[TBL] [Abstract][Full Text] [Related]
6. Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
Seehofer D; Rayes N; Berg T; Neuhaus R; Müller AR; Hopf U; Bechstein WO; Neuhaus P
Transpl Int; 2000; 13(4):290-6. PubMed ID: 10959482
[TBL] [Abstract][Full Text] [Related]
7. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
[TBL] [Abstract][Full Text] [Related]
8. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.
Singh N; Gayowski T; Wannstedt CF; Wagener MM; Marino IR
Transplantation; 1997 May; 63(10):1415-9. PubMed ID: 9175803
[TBL] [Abstract][Full Text] [Related]
10. Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.
Seehofer D; Rayes N; Steinmüller T; Müller AR; Jonas S; Settmacher U; Neuhaus R; Berg T; Neuhaus P
Z Gastroenterol; 2002 Sep; 40(9):795-9. PubMed ID: 12215948
[TBL] [Abstract][Full Text] [Related]
11. Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
Yoshida EM; Ma MM; Davis JE; Fischer KP; Kneteman NM; Erb SR; Tyrrell DL; Bain VG
Can J Gastroenterol; 1998 Mar; 12(2):125-9. PubMed ID: 9559207
[TBL] [Abstract][Full Text] [Related]
12. Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine.
Meisel H; Preikschat P; Reinke P; Hocher B; Budde K; Bechstein WO; Neuhaus P; Krüger DH; Neumayer HH
Transpl Int; 1999; 12(4):283-7. PubMed ID: 10460876
[TBL] [Abstract][Full Text] [Related]
13. [Prevention and treatment of HBV reinfection following liver transplantation].
Yuan G; Duan Y; Wang F; Liang S; Zhu L
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):14-6. PubMed ID: 11856491
[TBL] [Abstract][Full Text] [Related]
14. Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study.
Sangfelt P; Uhnoo I; Hollander A; Lindh G; Weiland O
Scand J Infect Dis; 2002; 34(7):505-11. PubMed ID: 12195876
[TBL] [Abstract][Full Text] [Related]
15. Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation.
Haller GW; Bechstein WO; Neuhaus R; Raakow R; Berg T; Hopf U; Neuhaus P
Transpl Int; 1996; 9 Suppl 1():S210-2. PubMed ID: 8959829
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
Zheng SS; Wu J; Liang TB; Wang WL; Huang DS; Xu X
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):327-9. PubMed ID: 14607701
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation.
Rayes N; Seehofer D; Bechstein WO; Müller AR; Berg T; Neuhaus R; Neuhaus P
Clin Transplant; 1999 Dec; 13(6):447-52. PubMed ID: 10617232
[TBL] [Abstract][Full Text] [Related]
18. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
Akyildiz M; Karasu Z; Zeytunlu M; Aydin U; Ozacar T; Kilic M
J Gastroenterol Hepatol; 2007 Dec; 22(12):2130-4. PubMed ID: 18031370
[TBL] [Abstract][Full Text] [Related]
19. Developing strategies for prevention and treatment of recurrent HBV in liver transplantation.
Nery JR; Weppler D; Lavandera R; Nery Avila C; Magill A; Rodriguez M; Reddy KR; Schiff E; Tzakis AG
Transplant Proc; 1999; 31(1-2):485-6. PubMed ID: 10083202
[No Abstract] [Full Text] [Related]
20. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]